Back
Compare AU
Compare REIT vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck Ftse International Property (Aud Hedged) ETF (REIT) and the Betashares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
REIT | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 97 | 74 |
Median incremental investment | $993.50 | $735.27 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,383.36 | $2,083.20 |
Average age group | > 35 | > 35 |
Key Summary
REIT | DRUG | |
|---|---|---|
Strategy | REIT.AX was created on 2019-03-29 by VanEck. The fund's investment portfolio concentrates primarily on real estate equity. REIT.AX seeks to provide investors with access to a diversified portfolio of international property securities | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Welltower Inc (9.84 %) Prologis Inc (7.49 %) Equinix Inc (5.95 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) BRL - BRAZILIAN REAL (0 %) |
Top 3 industries | Real Estate (100.00 %) Other (5.82 %) | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) |
Top 3 countries | United States (72.00 %) Japan (5.79 %) Singapore (3.61 %) | United States (69.91 %) Switzerland (10.93 %) United Kingdom of Great Britain and Northern Ireland (7.38 %) |
Management fee | 0.43 % | 0.57 % |
Key Summary
REIT | DRUG | |
|---|---|---|
Issuer | VanEck | BetaShares |
Tracking index | FTSE EPRA NAREIT Developed ex Australia Rental Hedged to AUD Index - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.43 % | 0.57 % |
Price | $15.72 | $9.30 |
Size | $772.871 million | $174.867 million |
10Y return | N/A | 97.87 % |
Annual distribution yield (5Y) | 4.32 % | 1.82 % |
Market | ASX | ASX |
First listed date | 02/04/2019 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
REIT | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 97 | 74 |
Median incremental investment | $993.50 | $735.27 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,383.36 | $2,083.20 |
Average age group | > 35 | > 35 |
Pros and Cons
REIT | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
REIT | DRUG |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |